Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
Fakhouri, Fadi; Delmas, Yahsou; Provot, François; Barbet, Christelle; Karras, Alexandre; Makdassi, Raifah; Courivaud, Cécile; Rifard, Khair; Servais, Aude; Allard, Catherine; Besson, Virginie; Cousin, Maud; Châtelet, Valérie; Goujon, Jean-Michel; Coindre, Jean-Philippe; Laurent, Guillaume; Loirat, Chantal; Frémeaux-Bacchi, Véronique.
Am J Kidney Dis
; 63(1): 40-8, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24021908
Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count.
Successful treatment of thrombotic microangiopathy associated with dengue infection: A case report and literature review.
Long-term outcomes of Shiga toxin hemolytic uremic syndrome.
Hemolytic-uremic syndrome: Findings of post-acute renal failure in light and electron microscopy.
Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study.
The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome.
Acute kidney injury in a patient with hemolytic anemia and thrombocytopenia.
Haemolytic-uremic syndrome due to infection with adenovirus: A case report and literature review.
[Pregnancy-related acute kidney injury].
A time for reappraisal of "atypical" hemolytic uremic syndrome: should all patients be treated the same?